Triazoloamides as potent γ-secretase modulators with reduced hERG liability. 2012

Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
Merck Research Laboratories Boston, 33 Avenue Louis Pasteur, Boston, MA 02115, USA. christian_fischer@merck.com

Synthesis and SAR studies of novel aryl triazoles as gamma secretase modulators (GSMs) are presented in this communication. Starting from our aryl triazole leads, optimization studies were continued and the series progressed towards novel amides and lactams. Triazole 57 was identified as the most potent analog in this series, displaying single-digit nanomolar Aβ42 IC(50) in cell-based assays and reduced affinity for the hERG channel.

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071230 Transcriptional Regulator ERG A trans-activator and member of the erythroblast transformation-specific family of transcriptions factors that contain a characteristic ETS MOTIF. It is required for PLATELET CELL ADHESION to the subendothelium and associates with CHIMERIC ONCOGENE PROTEINS in PROSTATE CANCER; EWING'S SARCOMA; and ACUTE MYELOID LEUKEMIA. Transforming Protein ERG,V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog Protein,V-Ets Avian Erythroblastosis Virus E26 Oncogene Related Protein,V Ets Avian Erythroblastosis Virus E26 Oncogene Homolog Protein,V Ets Avian Erythroblastosis Virus E26 Oncogene Related Protein
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid

Related Publications

Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
September 2015, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
January 2011, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
September 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
November 2011, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
September 2013, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
December 2014, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
May 2014, European journal of medicinal chemistry,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
June 2011, ACS medicinal chemistry letters,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
April 2010, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Susan L Zultanski, and Hua Zhou, and Joey L Methot, and Sanjiv Shah, and Hugh Nuthall, and Bethany L Hughes, and Nadja Smotrov, and Armetta Hill, and Alexander A Szewczak, and Christopher M Moxham, and Nathan Bays, and Richard E Middleton, and Benito Munoz, and Mark S Shearman
February 2008, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!